Biological Engineering
Antibody-peptide inhibitor conjugates: a new path for cancer therapy
Research
EPFL
Cancer treatments often struggle with balancing efficacy and side effects. A new study by EPFL scientists offers a promising solution using antibody-peptide inhibitor conjugates to target specific cell types and block the activity of cancer-promoting enzymes called cathepsins.
New cells could be key to treating obesity
Research
EPFL
New cells discovered in human omental adipose tissue inhibit fat cell formation, revealing why ‘apple’ body shapes may pose higher metabolic health risks.
Mini-colons revolutionize colorectal cancer research
Research
EPFL
In a breakthrough for cancer research, scientists at EPFL have created lab-grown mini-colons that can accurately mimic the development of colorectal tumors, offering a powerful new tool for studying and testing treatments for the disease.
Cutting-edge research from Basel
Research
ETH Zurich
From new tests and therapies to the fundamental principles of biology: five compelling examples of the benefits of new bioengineering technologies.
Protein modifications key influencers in neurodegenerative diseases
Research
EPFL
Exploring the post-translational modifications of a key protein in Parkinson's disease, researchers at EPFL and USC uncover potential pathways for future therapies in neurodegenerative diseases in general.
AI unlocks new insights in neurodegenerative disease research
Research
EPFL
EPFL researchers develop an AI-driven, label-free method for studying protein aggregates, offering new perspectives in neurodegenerative disease research.
Page 2 of 9